Association of apolipoprotein e (ApoE) polymorphism with alzheimer’s disease in Chinese population

Current Alzheimer Research

Volumn 13, Issue 8, 2016, Pages 912-917

  Zheng, Lingling ^a   Duan, Jianzhong ^a   Duan, Xiaoling ^a   Zhou, Weitao ^a   Chen, Chunjiang ^a   Li, Yanhua ^a   Chen, Jie ^a   Zhou, Weihui ^a   Wang, Yan Jiang ^b   Li, Tingyu ^a   Song, Weihong ^a,c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer s disease; Apolipoprotein E; China; Gnotype; Plymorphism; Population

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; MIDDLE AGED;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; MALE; MIDDLE AGED;

EID: 84975470778     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205013666160401115307     Document Type: Article

References (39)

1. Alzheimer's Association. Alzheimer's disease facts and figures. Alzheimer's Dement 7: 1-38 (2011).
2. Zhang S, Zhang M, Cai F, Song W. Biological function of Presenilin and its role in AD pathogenesis. Transl Neurodegener 2: 15 (2013).
3. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093 (2009).
4. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: 1832-1840 (2010).
5. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099 (2009).
6. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet Nat Genet 43(5): 436-441 (2011).
7. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43(5): 429-435 (2011).
8. Mahley RW, Innerarity TL, Jr. Rall SC, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 25: 1277-1294 (1984).
9. Das HK, McPherson J, Bruns GA, Karathanasis SK, Breslow JL. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 260: 6240-6247 (1985).
10. Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci USA 82: 3445-3449 (1985).
11. Evans RM, Hui S, Perkins A, Lahiri DK, Poirier J, Farlow MR. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 62: 1869-1871 (2004).
12. Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci 6: 345-351 (2003).
13. Main BF, Jones PJ, MacGillivray RT, Banfield DK. Apolipoprotein E genotyping using the polymerase chain reaction and allelespecific oligonucleotide primers. J Lipid Res 32: 183-187 (1991).
14. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548 (1990).
15. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3: 373-379 (1988).
16. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49: 338-349 (1991).
17. Bolla MK, Haddad L, Humphries SE, Winder AF, Day IN. Highthroughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis. Clin Chem 41: 1599-1604 (1995).
18. Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP. Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. J Biol Chem 253: 6289-6295 (1978).
19. Kanekiyo T, Xu H, Bu G. ApoE and Abeta in Alzheimer's disease: accidental encounters or partners? Neuron 81: 740-754 (2014).
20. Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9: 106-118 (2013).
21. Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, et al. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch Neurol 59: 594-600 (2002).
22. Volcik KA, Barkley RA, Hutchinson RG, Mosley TH, Heiss G, Sharrett AR, et al. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants. Am J Epidemiol 164: 342-348 (2006).
23. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298: 1300-1311 (2007).
24. Kolovou GD, Anagnostopoulou KK. Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Res Rev 6: 94-108 (2007).
25. Anoop S, Misra A, Meena K, Luthra K. Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases. Indian J Med Res 132: 363-378 (2010).
26. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 11: 1237-1244 (1991).
27. Huang W, Chen M, Zhang Y, Zhao P, Yao G, Zhou H. Frequency distribution of apolipoprotein e genotypes in elderly han chinese population and relationship with senile dementia. J Neurosurg Sci (2014).
28. Maloney B, Ge YW, Petersen RC, Hardy J, Rogers JT, Perez-Tur J, et al. Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions. Am J Med Genet B Neuropsychiatr Genet 153B: 185-201 (2010).
29. Juhasz A, Palotas A, Janka Z, Rimanoczy A, Palotas M, Bodi N, et al. ApoE-491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population. Neurochem Res 30: 591-596 (2005).
30. Norrman J, Brookes AJ, Yates C, St Clair D. Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease. Br J Psychiatry 167: 533-536 (1995).
31. Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 50: 961-965 (1998).
32. Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology 48: 515-519 (1997).
33. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699 (1993).
34. Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, et al. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett 375: 1-6 (2005).
35. Bazrgar M, Karimi M, Fathzadeh M, Senemar S, Peiravian F, Shojaee A, et al. Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts. Mol Biol Rep 35: 495-499 (2008).
36. Lehtovirta M, Helisalmi S, Mannermaa A, Soininen H, Koivisto K, Ryyanen M, et al. Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland. Neurosci Lett 185: 13-15 (1995).
37. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Myers RH, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349-1356 (1997).
38. Zhou X, Miao H, Rausch WD, Long M, Luo X, Yu H, et al. Association between apolipoprotein E gene polymorphism and Alzheimer's disease in Uighur and Han populations. Psychogeriatrics 12: 83-87 (2012).
39. Wu YN, Zhang JW, Zhang ZX, Qu QM, Chen D. An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 23: 450-454 (2001).